Ca2+ and CaMKII cascade contribute to MPF inactivation and premature MAPK decline. Ca2+-free medium, Ca2+ chelator, Ca2+ channel blockers, NCX1 activator, and CaMKII inhibitors have been applied, but these methods cannot fully block OSA or can cause obvious side effects. The gene discussed is CAMK2G; the disease is obstructive sleep apnea syndrome.